Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 1;3(5):e0000488.
doi: 10.1371/journal.pdig.0000488. eCollection 2024 May.

Addressing the affordability gap of novel cancer treatments in developing countries

Gavin Miyasato  1 , Chitrang Shah  2 , Todd Gorsuch  1 , Ramnath Venkateswaran  2 , Vamsi Chandra Kasivajjala  1 , Mohit Misra  1
Affiliations

Addressing the affordability gap of novel cancer treatments in developing countries

Gavin Miyasato et al. PLOS Digit Health. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Organization for Economic Cooperation and Development. Addressing Challenges in Access to Oncology Medicines–Analytical Report. Paris (France): Organization for Economic Cooperation and Development; 2020.
    1. Noronha V, Abraham G, Patil V, Joshi A, Menon N, Mahajan A, et al.. A real-world data of Immune checkpoint inhibitors in solid tumors from India. Cancer Med. 2021. Mar;10(5):1525–1534. doi: 10.1002/cam4.3617 - DOI - PMC - PubMed
    1. Johnson DB, Nebhan CA, Moslehi JJ, Balko JM. Immune-checkpoint inhibitors: long-term implications of toxicity. Nat Rev Clin Oncol. 2022. Apr;19(4):254–267. doi: 10.1038/s41571-022-00600-w - DOI - PMC - PubMed
    1. Das S, Johnson DB. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors. J Immunother Cancer. 2019. Nov 15;7(1):306. doi: 10.1186/s40425-019-0805-8 - DOI - PMC - PubMed
    1. Gupta VG, Rangaraju RR, Abbas W, Bajpai P, Khetrapal R. Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy. South Asian J Cancer. 2019. Jan-Mar;8(1):65–68. doi: 10.4103/sajc.sajc_167_18 - DOI - PMC - PubMed

LinkOut - more resources